BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 10357853)

  • 21. Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.
    Cereseto A; Mulloy JC; Franchini G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S69-75. PubMed ID: 8797707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.
    Jain P; Lavorgna A; Sehgal M; Gao L; Ginwala R; Sagar D; Harhaj EW; Khan ZK
    Retrovirology; 2015 Feb; 12():23. PubMed ID: 25809782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
    Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI
    J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells.
    Olagnier D; Sze A; Bel Hadj S; Chiang C; Steel C; Han X; Routy JP; Lin R; Hiscott J; van Grevenynghe J
    PLoS Pathog; 2014 Dec; 10(12):e1004575. PubMed ID: 25521510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.
    Mulloy JC; Kislyakova T; Cereseto A; Casareto L; LoMonico A; Fullen J; Lorenzi MV; Cara A; Nicot C; Giam C; Franchini G
    J Virol; 1998 Nov; 72(11):8852-60. PubMed ID: 9765430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.
    Moriuchi H; Moriuchi M; Fauci AS
    J Exp Med; 1998 May; 187(10):1689-97. PubMed ID: 9584147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.
    Persaud D; Muñoz JL; Tarsis SL; Parks ES; Parks WP
    J Virol; 1995 Oct; 69(10):6297-303. PubMed ID: 7666530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Majority of interferon-gamma-producing CD4+ cells in patients infected with human T cell lymphotrophic virus do not express tax protein.
    Mitre E; Thompson RW; Carvalho EM; Nutman TB; Neva FA
    J Infect Dis; 2003 Aug; 188(3):428-32. PubMed ID: 12870125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.
    Manuel SL; Schell TD; Acheampong E; Rahman S; Khan ZK; Jain P
    J Leukoc Biol; 2009 Nov; 86(5):1205-16. PubMed ID: 19656902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
    Höllsberg P; Weber WE; Dangond F; Batra V; Sette A; Hafler DA
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4036-40. PubMed ID: 7732026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.
    Prince HE; York J; Golding J; Owen SM; Lal RB
    Clin Diagn Lab Immunol; 1994 May; 1(3):273-82. PubMed ID: 7496962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
    Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection.
    Mosley AJ; Meekings KN; McCarthy C; Shepherd D; Cerundolo V; Mazitschek R; Tanaka Y; Taylor GP; Bangham CR
    Blood; 2006 Dec; 108(12):3801-7. PubMed ID: 16912225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
    Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
    J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.
    Hieshima K; Nagakubo D; Nakayama T; Shirakawa AK; Jin Z; Yoshie O
    J Immunol; 2008 Jan; 180(2):931-9. PubMed ID: 18178833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.